Cargando…
Omalizumab and mepolizumab in the landscape of biological therapy for severe asthma in children: how to choose?
Severe asthma has a substantial epidemiological impact on children and biological treatments can be an option to take into account, as they target specific molecules and pathways involved in its pathogenesis. Modern medicine is continuously and progressively oriented towards tailored treatments desi...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6883618/ https://www.ncbi.nlm.nih.gov/pubmed/31779657 http://dx.doi.org/10.1186/s13052-019-0737-4 |